Paris (ots/PRNewswire) - The French environment agency ADEME is supporting Valeo research projects. Two projects for low-CO2 vehicles, which have received 6 million euros in funding from ADEME, were presented yesterday at the French Sustainable Development Ministry: - Mild hybrid (MHYGALE project) Following the micro hybrid, mild hybridization represents ...
Luxembourg (ots/PRNewswire) - In a breakthrough for microfinance and alternative investment, the LeapFrog Financial Inclusion Fund announced today that it has raised US$44 million. It is the world's first investment fund focused on microinsurance. The fund aims to invest in businesses that will bring insurance and financial services to 25 million low-income people in Africa and Asia. The capital was raised from ...
London (ots/PRNewswire) - In an agreement that marks one of the largest mergers ever in the public relations industry, Ketchum, a leading global public relations firm, and Pleon, Europe's largest strategic communications consultancy, have announced today they will combine operations. The merger creates one of the largest, most geographically diverse ...
San Jose, California (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML) and HomeATM announced today that the recent Payments Card Industry (PCI) 2.0 certification of HomeATM's Safe-T-PIN(TM) is the result of an efficient collaboration between the two leaders on their markets. HomeATM's Safe-T-PIN, powered ...
Perimeter Institute for Theoretical Physics
Waterloo, Ontario (ots/PRNewswire) - For 10 exciting days this October, Canada's Perimeter Institute's 10th anniversary science celebration "Quantum to Cosmos: Ideas for the Future" will take a global audience from the strange subatomic world to the outer frontiers of the universe. Events will take place from October 15 to 25, 2009, commemorating the 10th ...
Maidenhead, England (ots/PRNewswire) - - Two-year Data From COMET Study in Early Active Moderate-to-Severe Rheumatoid Arthritis Indicated Sustained Halt of Progressive Joint Damage - New Analyses From ASCEND Study in Ankylosing Spondylitis Indicated Improvement in Patients With and Without Peripheral ...
Collegeville, Pennsylvania (ots/PRNewswire) - New data from Phase 3 European clinical trials reinforce that Wyeth's (NYSE: WYE) investigational pneumococcal vaccine, Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine, 13-valent [Adsorbed]), has the potential to provide coverage against the 13 most ...
Bourne End, England (ots/PRNewswire) - - Feature-Rich, Value-Priced Bundle Offers a Complete Card Design and Printing Solution for Small and Medium-Size Organisations Zebra Technologies Europe Limited, a global leader in specialty printing and automatic identification solutions, today announced the launch ...
Paris (ots/PRNewswire) - Valeo's Combined Annual General Shareholders' Meeting (AGM) was held today under the chairmanship of Pascal Colombani, Chairman of Valeo. The AGM approved the 2008 accounts which were published on February 13, 2009. The presentation of the Group's results for 2008 and the first quarter 2009 provided an opportunity for Jacques Aschenbroich, the new CEO of Valeo, to review the situation of ...
San Jose, California (ots/PRNewswire) - - Free Windows Embedded CE and Linux BSPs Provided to Facilitate Application Development Atmel(R) Corporation (Nasdaq: ATML) announced today the release of its SAM9G10 ARM926EJ-S-based embedded microprocessor. The SAM9G10 is an upgrade to the established SAM9261S embedded microprocessor that pushes the boundaries of ...
San Jose, California (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML) announced today the new release of the popular Atmel QTouch Library, a royalty free software library providing access to the industry-leading QTouch(TM) technology. Without the need for external devices, the QTouch Library adds capacitive touch capabilities to AVR(R) and AVR32 microcontrollers. The new library consists of pre-compiled and ...
Excellence in Epilepsy Journalism Award
Brussels (ots/PRNewswire) - The 'Excellence in Epilepsy' Journalism Award - an initiative of the International Bureau for Epilepsy (IBE) and UCB - invites journalists from around the world to submit stimulating, informed and compelling news and feature stories on epilepsy. The award seeks to increase awareness and improve understanding of epilepsy. The closing ...
Ingelheim, Germany (ots/PRNewswire) - - Results From Linagliptin Study in Type 2 Diabetes Patients Who Were Inadequately Controlled on Metformin Therapy Alone, Presented at Major Diabetes Meeting Study results presented for the first time in the scientific sessions of this year's American Diabetes ...
San Jose, California (ots/PRNewswire) - - Atmel's Host CryptoAuthentication IC Eliminates the Need for Designers to Understand Complex Cryptographic Protocols and Algorithms Atmel(R) Corporation (Nasdaq: ATML) announced today a "plug-and-play" CryptoAuthentication host-side IC (http://www.atmel.com/products/cryptoauthentication/default.asp)that allows ...
Maidenhead, England (ots/PRNewswire) - - CHMP Recommends Approval of a Continuous Dosing Regimen Option for Enbrel In Plaque Psoriasis, and a New Pre-Filled Pen Delivery Device Today, Wyeth received positive recommendations from the European Committee for Medicinal Products for Human Use (CHMP) for two ...
Basel, Switzerland (ots/PRNewswire) - - Not for US Media - New Ilaris Data in The New England Journal of Medicine Show Rapid Sustained Efficacy in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)(1) - CAPS is a Debilitating Genetic Disorder With Potentially Fatal Complications and Limited ...
Paris and Brisbane, California (ots/PRNewswire) - - Data Highlighted in Plenary Session of 2009 American Society of Clinical Oncology Annual Meeting Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and its fully owned subsidiary, BiPar Sciences, today announced results from a randomized Phase 2 clinical trial ...
Mumbai, India (ots/PRNewswire) - - Global Service Helps Customers Ensure Optimal IT Performance Tata Communications, a leading provider of a new world of communications, today announced the launch of Application Performance Visibility Service, a suite of integrated, end-to-end, network and application performance monitoring service with three-tiered ...
Basel, Switzerland (ots/PRNewswire) - - For Non-US Media Only New Phase III study results presented for the first time today at the ninth annual American Transplant Congress 2009 (ATC) demonstrate that doubling the duration of preventive therapy ('prophylaxis') with Valcyte (oral valganciclovir), ...
San Jose, California (ots/PRNewswire) - - SAM3U is Code Portable from Atmel's Established ARM7- and ARM9-based MCU Families Atmel(R) Corporation (Nasdaq: ATML) announced today the SAM3U, the industry's first ARM(R) Cortex(TM)-M3 Flash microcontroller integrating high speed (480 Mbps) USB ...
Basel, Switzerland (ots/PRNewswire) - - PLX4032 (R7204) Phase I Results Offer Hope of First Highly Effective Drug in Melanoma Along With Companion Diagnostic - For Non-US Media Only Roche announced today results from a Phase I study with PLX4032 (R7204) a new, highly selective and promising ...
Orlando, Florida (ots/PRNewswire) - Data from the Phase III ZODIAC(1) study in advanced non-small cell lung cancer patients, with the investigational drug vandetanib, were presented today at the American Society of Clinical Oncology (ASCO) meeting in Orlando. Results show that the study met its primary endpoint, ...
Basel, Switzerland (ots/PRNewswire) - - For ex-US Media Only - Phase III ATLAS Study Achieves a New Milestone in Treating Advanced Lung Cancer Roche announced today that the Phase III ATLAS study showed patients with advanced non-small cell lung cancer (NSCLC) who received Avastin(R) (bevacizumab) ...
Stichting Shell Reserves Compensation Foundation and Royal Dutch Shell plc
The Hague, The Netherlands (ots/PRNewswire) - The Hague - Today, the Amsterdam Court of Appeals has declared the Non-U.S. Settlement Agreement concerning the recategorisation by Shell of certain of its oil and gas reserves binding. The agreement provides relief in the amount of US$352.6 million to qualifying non-U.S. shareholders who bought Shell shares on any stock exchange outside the United States from 8 April 1999 ...
Basel, Switzerland (ots/PRNewswire) - - RIBBON-1 Study Confirms Benefit of Avastin in Treating HER2-Negative Breast Cancer - For Non-US, Non-UK and Non-Austrian Media Results from the phase III RIBBON-1 study presented today at ASCO showed that patients with advanced HER2-negative breast cancer ...
Collegeville, Pennsylvania (ots/PRNewswire) - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced preliminary data from two ongoing studies, one evaluating neratinib (HKI-272) in combination with trastuzumab (Herceptin(R), Roche) in HER-2 positive (ErbB-2 positive) breast cancer, and ...
Huizingen, Belgium (ots/PRNewswire) - RealDolmen, the independent single source ICT solutions provider and knowledge company, announces results for the fiscal year ended 31 March 2009, showing good growth across all metrics. Highlights of the year - Turnover up 5,6% - Operational result before nonrecurring items (REBIT) up 7,0 %, with REBIT margins up to 6,0%, despite incurred integration costs - ...
Huntington Beach, California, and Amsterdam (ots/PRNewswire) - Agendia, a world leader in molecular cancer diagnostics, today announced its strong support of Genentech's Citizen's Petition. Filed on December 5, 2008, Docket No. FDA-2008-P-0638-0001/CP petitions that all in vitro diagnostic tests be held to one ...
Ottawa, Canada and Fleurus, Belgium (ots/PRNewswire) - - Site to Provide Fluorodeoxyglucose (F-18 FDG) for use in Earlier Detection of Disease and Therapy Management MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals used in molecular medicine, today announced the opening of a facility in Fleurus, Belgium for the production ...
London (ots/PRNewswire) - - For Healthcare and Pharmaceutical Correspondents Only - NICE Recommends Considering DPP-4 Inhibitors as a Second Line Treatment Option in Appropriate Patients Merck Sharp & Dohme Limited (MSD) welcomes the publication of the guideline for type 2 diabetes newer agents1 from ...